Hui Yan

Hui Yan

Auto-generated profile, based on publicly available information

Hui Yan

Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute & Institute for Academic Medicine, Houston Methodist Hospital, Houston, Texas

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2018 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
HZHedong Zhang
Hedong Zhang
JWJie Wu
Jie Wu
DZDawei Zou
Dawei Zou
XXXiang Xiao
Xiang Xiao
HYHui Yan
Hui Yan
WCWenhao Chen
Wenhao Chen
Achieving transplant tolerance remains the ultimate goal in the field of organ transplantation. We demonstrated previously that ablation of the transcription factor interferon regulatory factor 4 (IRF4) in T cells induced heart transplant acceptance by driving allogeneic CD4+ T cell dysfunction. Herein, we showed that heart‐transplanted mice with T cell‐specific IRF4 deletion were tolerant to donor‐specific antigens and accepted the subsequently transplanted donor‐type but not third‐party skin allografts. Moreover, despite the rejection of the primary heart grafts in T cell‐specific Irf4 knockout mice under immune checkpoint blockade, the establishment of donor‐specific tolerance in these mice was unhindered. By tracking alloantigen‐specific CD4+ T cells in vivo, we revealed that checkpoint blockade restored the expression levels of the majority of wild‐type T cell‐expressed genes in Irf4‐deficient T cells on day 6 post‐heart grafting, indicating the initial reinvigoration of Irf4‐deficient T cells. Nevertheless, checkpoint blockade did not restore cell frequency, effector memory cell generation, and IFN‐γ/TNF‐α production of Irf4−/− alloreactive T cells at day 30 post‐heart grafting. Hence, targeting IRF4 represents a potential therapeutic strategy for driving intrinsic T cell dysfunction and achieving alloantigen‐specific transplant tolerance.

1 February 2020 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
AXAini Xie
Aini Xie
HYHui Yan
Hui Yan
JFJinfei Fu
Jinfei Fu
AHAdam He
Adam He
XXXiang Xiao
Xiang Xiao
WCWenhao Chen
Wenhao Chen